Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Campana

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Cardiovascular Medicine|November 10, 2025
Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approachesMichele Migliari, Luca Fazzini, Nicola Campana, et al.
Echocardiography (Mount Kisco, N.Y.)|May 4, 2026
Atrial Function and Volumetry in Cancer Therapy-Related Cardiotoxicity: Prognostic Insights and Emerging Imaging MarkersMichele Migliari, Anna Laura Vacca, Luca Fazzini, et al.
European Heart Journal. Case Reports|July 17, 2023
Catecholamine-induced Takotsubo syndrome: a case seriesNicola Campana, Alessandra Gioi, Maria Francesca Marchetti, et al.
The Journal of Sports Medicine and Physical Fitness|September 13, 2024
Feasibility of cardiopulmonary exercise test in an athlete who underwent total laringectomyCarlo Vignati, Nicola Campana, Alessandro Nava, et al.
Journal of Clinical Medicine|June 13, 2025
Exercise Prescription in Cardio-OncologyNicola Campana, Luca Fazzini, Clelia Donisi, et al.
Journal of Clinical Medicine|February 26, 2025
Genetic Background in Patients with Cancer Therapy-Induced CardiomyopathyLuca Fazzini, Nicola Campana, Stefano Cossu, et al.
Frontiers in Cardiovascular Medicine|November 27, 2025
Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysisLuca Fazzini, Simone Angius, Nicola Campana, et al.
Metabolites|February 26, 2026
Metabolomic Signatures and Advanced Echocardiography Highlight Clinical Risk and Early Cardiac Changes in Systemic Lupus Erythematosus: Six-Year Follow-UpNicola Campana, Michele Migliari, Antonio Deidda, et al.
Heart (British Cardiac Society)|April 16, 2025
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
European Journal of Preventive Cardiology|August 12, 2025
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptationRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Cardiovascular Medicine|November 10, 2025
Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approachesMichele Migliari, Luca Fazzini, Nicola Campana, et al.
Echocardiography (Mount Kisco, N.Y.)|May 4, 2026
Atrial Function and Volumetry in Cancer Therapy-Related Cardiotoxicity: Prognostic Insights and Emerging Imaging MarkersMichele Migliari, Anna Laura Vacca, Luca Fazzini, et al.
European Heart Journal. Case Reports|July 17, 2023
Catecholamine-induced Takotsubo syndrome: a case seriesNicola Campana, Alessandra Gioi, Maria Francesca Marchetti, et al.
The Journal of Sports Medicine and Physical Fitness|September 13, 2024
Feasibility of cardiopulmonary exercise test in an athlete who underwent total laringectomyCarlo Vignati, Nicola Campana, Alessandro Nava, et al.
Journal of Clinical Medicine|June 13, 2025
Exercise Prescription in Cardio-OncologyNicola Campana, Luca Fazzini, Clelia Donisi, et al.
Journal of Clinical Medicine|February 26, 2025
Genetic Background in Patients with Cancer Therapy-Induced CardiomyopathyLuca Fazzini, Nicola Campana, Stefano Cossu, et al.
Frontiers in Cardiovascular Medicine|November 27, 2025
Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysisLuca Fazzini, Simone Angius, Nicola Campana, et al.
Metabolites|February 26, 2026
Metabolomic Signatures and Advanced Echocardiography Highlight Clinical Risk and Early Cardiac Changes in Systemic Lupus Erythematosus: Six-Year Follow-UpNicola Campana, Michele Migliari, Antonio Deidda, et al.
Heart (British Cardiac Society)|April 16, 2025
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
European Journal of Preventive Cardiology|August 12, 2025
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptationRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Pageof 2